Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Literature DB >> 23956208

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P Moreau¹, J San Miguel, H Ludwig, H Schouten, M Mohty, M Dimopoulos, M Dreyling.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23956208 DOI： 10.1093/annonc/mdt297

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

61 in total

1. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.

Authors: Ying Chen; David R Lairson; Wenyaw Chan; Xianglin L Du
Journal: Med Oncol Date: 2017-08-03 Impact factor: 3.064

2. Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma.

Authors: Pieter Sonneveld; Emilie Asselbergs; Sonja Zweegman; Bronno van der Holt; Marie Jose Kersten; Edo Vellenga; Marinus van Marwijk-Kooy; Annemiek Broyl; Okke de Weerdt; Sarah Lonergan; Antonio Palumbo; Henk Lokhorst
Journal: Blood Date: 2014-11-14 Impact factor: 22.113

3. Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma.

Authors: L Giaccone; L Brunello; M Festuccia; M Gilestro; E Maffini; F Ferrando; E Talamo; R Passera; M Boccadoro; P Omedè; B Bruno
Journal: Bone Marrow Transplant Date: 2015-02-09 Impact factor: 5.483

Review 4. European perspective on multiple myeloma treatment strategies in 2014.

Authors: Heinz Ludwig; Pieter Sonneveld; Faith Davies; Joan Bladé; Mario Boccadoro; Michele Cavo; Gareth Morgan; Javier de la Rubia; Michel Delforge; Meletios Dimopoulos; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Philippe Moreau; Hareth Nahi; Torben Plesner; Jesús San-Miguel; Roman Hajek; Pia Sondergeld; Antonio Palumbo
Journal: Oncologist Date: 2014-07-25

5. Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma.

Authors: Meletios A Dimopoulos; Robert Z Orlowski; Thierry Facon; Pieter Sonneveld; Kenneth C Anderson; Meral Beksac; Lotfi Benboubker; Huw Roddie; Anna Potamianou; Catherine Couturier; Huaibao Feng; Ozlem Ataman; Helgi van de Velde; Paul G Richardson
Journal: Haematologica Date: 2014-09-26 Impact factor: 9.941

Review 6. Elotuzumab: A Review in Relapsed and/or Refractory Multiple Myeloma.

Authors: Yvette N Lamb
Journal: Drugs Date: 2018-09 Impact factor: 9.546

7. Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.

Authors: Michel Delforge; Leonard Minuk; Jean-Claude Eisenmann; Bertrand Arnulf; Letizia Canepa; Alberto Fragasso; Serge Leyvraz; Christian Langer; Yousef Ezaydi; Dan T Vogl; Pilar Giraldo-Castellano; Sung-Soo Yoon; Charles Zarnitsky; Martine Escoffre-Barbe; Bernard Lemieux; Kevin Song; Nizar Jacques Bahlis; Shien Guo; Mara Silva Monzini; Annette Ervin-Haynes; Vanessa Houck; Thierry Facon
Journal: Haematologica Date: 2015-03-13 Impact factor: 9.941